Biotricity reports FY25 EPS (56c) vs. ($1.66) last year
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 17 2025
0mins
Financial Performance: Biotricity reported a revenue increase to $13.8 million for fiscal 2025, driven by workflow automation and AI enhancements, moving closer to EBITDA breakeven and long-term profitability.
Strategic Developments: The company is expanding its Cardiac AI Cloud platform through partnerships, aiming for FDA clearance of its AI clinical model, and targeting access to 90% of U.S. hospitals while entering new verticals in managed care programs.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
